Leptin, visfatin, insulin resistance, and body composition change in chronic obstructive pulmonary disease

Abstract

These results may be earlier signs for further diseases that can emerge in the advanced stages in patients with COPD. Evaluating the patients not only with the pulmonary function and also systemically, contributes to minimizing the mortality and morbidity.

References

Page 1

	Year	Citations
ATS Statement American Journal of Respiratory and Critical Care Medicine	2002	10.5K
Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study Christopher J L Murray, Alan D López The Lancet Cause 1990–2020Health SystemsGlobal BurdenEpidemiological TrendPreventive Medicine	1997	7K
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper Bartolomé R. Celli, William MacNee, Àlvar Agustí, European Respiratory Journal Acute Lung InjuryPulmonary CareAdvanced Lung DiseaseLung InflammationDiagnosis	2004	4.4K
Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin Atsunori Fukuhara, Morihiro Matsuda, Masako Nishizawa, Science	2004	1.9K
The Homeostasis Model in the San Antonio Heart Study Steven M. Haffner, Heikki Miettinen, Michael P. Stern Diabetes Care	1997	790
Patterns of Comorbidities in Newly Diagnosed COPD and Asthma in Primary Care Joan B. Soriano, George Visick, Hana Muellerova, CHEST Journal AsthmaPrimary CarePulmonary CareRespiratory DiseasesClinical Epidemiology	2005	609
Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease M.P. Engelen, Annemie M.W.J. Schols, Joan D. Does, American Journal of Clinical Nutrition Extremity Fat-free MassPulmonary CirculationAdvanced Lung DiseaseAirflow ObstructionPhysiology	2000	228
Circulating Leptin in Patients with Chronic Obstructive Pulmonary Disease Noriaki Takabatake, Hidenori Nakamura, Shuichi Abe, American Journal of Respiratory and Critical Care Medicine ObesityInflammationMetabolic SyndromeBody CompositionMetabolic Disorder	1999	205
A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease Nicholas S Hopkinson, Rachel Tennant, Mark Dayer, Respiratory Research	2007	196
Insulin Resistance and inflammation—A Further Systemic Complication of COPD Charlotte E. Bolton, Marc Evans, A Ionescu, COPD Journal of Chronic Obstructive Pulmonary Disease	2007	143

Page 1